Skip to main content

Table 2 Logistic regression model in 427 patients with HIV/HBVco-infection according to anti-HBV treatment status

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

  Never treated vs treated patients adjusted OR  
Characteristics (95% CI) P
N. enrolled per center§   
≥20 patients 1.41 (0.73-2.71) 0.31
Female gender 0.83 (0.39-1.77) 0.64
Immigrant status   
Foreign birth 0.74 (0.3-1.8) 0.51
Age at diagnosis   
10 years increase 0.78 (0.55-1.11) 0.17
Years since diagnosis*   <0.001
2-10 0.17 (0.08-0.36)
<10 0.08 (0.03-0.25)
Alcohol consumption   
Ever 1.51 (0.63-3.62) 0.35
Disease stage°   
cirrhosis/HCC 0.39 (0.09-1.78) 0.22
HBeAg   
positivity 0.57 (0.28-1.14) 0.11
HCV co-infection   
yes 0.91 (0.41-2.02) 0.82
HDV co-infection   
yes 0.48 (0.14-1.66) 0.25
  1. Reference: § = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.